|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 294.30 DKK | +3.85% |
|
-9.81% | -36.90% |
| 11:03am | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 09:27am | Wolfe Downgrades Zealand Pharma Following Weak Tolerability Data for Obesity Drug | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZEALAND PHARMA A/S | Bio Therapeutic Drugs | +3.85% | -9.81% | -36.90% | -39.36% | +48.64% | 3.08B |  | | |
- Stock Market
- Stocks
- ZEAL Stock
- Charts Zealand Pharma A/S
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
